NXSN:TASENextVison Stabilized Systems, Ltd. Analysis
Data as of 2026-03-11 - not real-time
$122.63
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
NXSN is trading at $122.63, essentially at its 52‑week high of $123.19 and comfortably above its 20‑day ($104.23), 50‑day ($91.01) and 200‑day ($55.06) simple moving averages, indicating strong bullish momentum. The RSI sits at 67, below overbought territory, while the MACD histogram remains positive, reinforcing the bullish trend, though the 30‑day volatility is extreme at roughly 99% and daily volume is thin (≈112 shares), suggesting price swings could be sharp.
Fundamentally, the company boasts impressive 62% revenue growth, gross margins above 71% and operating margins near 60%, supported by a solid cash pile of $529 M and modest debt. However, valuation metrics are starkly misaligned: a trailing PE of 115 versus an industry average of 29, a price‑to‑book of 17.4, and a discounted‑cash‑flow fair value of just $16.46 highlight severe overvaluation, while the modest 0.4% dividend yield with a 38% payout ratio appears sustainable.
Fundamentally, the company boasts impressive 62% revenue growth, gross margins above 71% and operating margins near 60%, supported by a solid cash pile of $529 M and modest debt. However, valuation metrics are starkly misaligned: a trailing PE of 115 versus an industry average of 29, a price‑to‑book of 17.4, and a discounted‑cash‑flow fair value of just $16.46 highlight severe overvaluation, while the modest 0.4% dividend yield with a 38% payout ratio appears sustainable.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price at near 52‑week high with limited upside
- Extreme short‑term volatility and thin trading volume
- Technical indicators still bullish but risk of pull‑back
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth and margins support longer‑term prospects
- Valuation remains far above intrinsic value
- Potential correction as market re‑prices the stock
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Sustained high margins and cash generation in a niche defense market
- Overvaluation may persist, requiring a price decline before entry
- Geopolitical and regulatory environment adds uncertainty
Key Metrics & Analysis
Financial Health
Revenue Growth62.30%
Profit Margin59.53%
P/E Ratio114.6
ROE25.65%
ROA15.66%
Debt/Equity0.59
P/B Ratio17.4
Op. Cash Flow$56.9M
Free Cash Flow$26.8M
Industry P/E29.3
Technical Analysis
TrendBullish
RSI67.3
Support$92.56
Resistance$123.19
MA 20$104.23
MA 50$91.01
MA 200$55.06
MACDBullish
VolumeStable
Fear & Greed Index78.16
Valuation
Fair Value$16.46
GradeOvervalued
TypeGrowth
Dividend Yield0.40%
Risk Assessment
Beta0.17
Volatility99.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.